BUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit

Reuters

Jul 09, 2025

BUZZ-<a href="https://laohu8.com/S/MRNA">Moderna</a> shares jump, analysts cite U.S. HHS lawsuit

** Shares of vaccine maker Moderna MRNA.O up 11% at $33.20

** On Monday, leading medical organizations filed a lawsuit against U.S. Health Secretary Robert F. Kennedy Jr. and Department of Health and Human Services, arguing that current policies on COVID-19 vaccines pose an imminent threat to public health

** B. Riley Securities analyst Mayank Mamtani said the share movement likely reflects "a reversal of peak negative investor sentiment, with now there being some near-term events, both vaccine advisory committee (VRBPAC) and lawsuit-related."

** Other vaccine makers like Pfizer PFE.N and Novavax NVAX.O up 1.6% and 6.7%, respectively

** Mamtani cites recent late-stage study data for COVID-influenza combination and standalone flu vaccines as an additional driver for NVAX stock

** Including sessions' moves, MRNA has lost 20.2% YTD, while NVAX is down 11.4%

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2550032521"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2550032521\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2550032521?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-09 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550032521","market":"us","top_or_hot":-1,"title":"BUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/MRNA\">Moderna</a> shares jump, analysts cite U.S. HHS lawsuit</title></head><body><p>** Shares of vaccine maker Moderna <span>MRNA.O</span> up 11% at $33.20 </p><p>** On Monday, leading medical organizations <span>filed a lawsuit</span> against U.S. Health Secretary Robert F. Kennedy Jr. and Department of Health and Human Services, arguing that current policies on COVID-19 vaccines pose an imminent threat to public health</p><p>** <a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Securities analyst Mayank Mamtani said the share movement likely reflects \"a reversal of peak negative investor sentiment, with now there being some near-term events, both vaccine advisory committee (VRBPAC) and lawsuit-related.\"</p><p>** Other vaccine makers like Pfizer <span>PFE.N</span> and Novavax <span>NVAX.O</span> up 1.6% and 6.7%, respectively</p><p>** Mamtani cites recent late-stage study data for COVID-influenza combination and standalone flu vaccines as an additional driver for NVAX stock</p><p>** Including sessions' moves, MRNA has lost 20.2% YTD, while NVAX is down 11.4% </p><p> (Reporting by Siddhi Mahatole)</p><p> ((siddhi.mahatole@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-09 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/MRNA\">Moderna</a> shares jump, analysts cite U.S. HHS lawsuit</title></head><body><p>** Shares of vaccine maker Moderna <span>MRNA.O</span> up 11% at $33.20 </p><p>** On Monday, leading medical organizations <span>filed a lawsuit</span> against U.S. Health Secretary Robert F. Kennedy Jr. and Department of Health and Human Services, arguing that current policies on COVID-19 vaccines pose an imminent threat to public health</p><p>** <a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Securities analyst Mayank Mamtani said the share movement likely reflects \"a reversal of peak negative investor sentiment, with now there being some near-term events, both vaccine advisory committee (VRBPAC) and lawsuit-related.\"</p><p>** Other vaccine makers like Pfizer <span>PFE.N</span> and Novavax <span>NVAX.O</span> up 1.6% and 6.7%, respectively</p><p>** Mamtani cites recent late-stage study data for COVID-influenza combination and standalone flu vaccines as an additional driver for NVAX stock</p><p>** Including sessions' moves, MRNA has lost 20.2% YTD, while NVAX is down 11.4% </p><p> (Reporting by Siddhi Mahatole)</p><p> ((siddhi.mahatole@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL4N3T515F:1","article_id":"2550032521","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550032521","pubTimestamp":1751991879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit** Shares of vaccine maker Moderna MRNA.O up 11% at $33.20 ** On Monday, leading medical organizations filed a lawsuit against U.S. Health Secretary Robert F. Kennedy Jr. and Department of Health and Human Services, arguing that current policies on COVID-19 vaccines pose an imminent threat to public health** B. Riley Securities analyst Mayank Mamtani said the share movement likely reflects \"a reversal of peak negative investor sentiment, with now there being some near-term events, both vaccine advisory committee  and lawsuit-related.\"** Other vaccine makers like Pfizer PFE.N and Novavax NVAX.O up 1.6% and 6.7%, respectively** Mamtani cites recent late-stage study data for COVID-influenza combination and standalone flu vaccines as an additional driver for NVAX stock** Including sessions' moves, MRNA has lost 20.2% YTD, while NVAX is down 11.4%   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4547":"WSB热门概念","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","NVAX":"诺瓦瓦克斯医药","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4592":"伊斯兰概念","LU0234572021.USD":"高盛美国核心股票组合Acc","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","BK4568":"美国抗疫概念","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4588":"碎股","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK4007":"制药","SG9999001176.USD":"United Global Healthcare Acc USD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4551":"寇图资本持仓","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","MRNA":"Moderna, Inc.","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4532":"文艺复兴科技持仓","BK4581":"高盛持仓","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4599":"减肥药","BK4501":"段永平概念","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓"},"translate_title":"BUZZ-Moderna股价上涨，分析师援引美国HHS诉讼","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"NVAX":0.9},"content_text":"BUZZ-Moderna shares jump, analysts cite U.S. HHS lawsuit** Shares of vaccine maker Moderna MRNA.O up 11% at $33.20 ** On Monday, leading medical organizations filed a lawsuit against U.S. Health Secretary Robert F. Kennedy Jr. and Department of Health and Human Services, arguing that current policies on COVID-19 vaccines pose an imminent threat to public health** B. Riley Securities analyst Mayank Mamtani said the share movement likely reflects \"a reversal of peak negative investor sentiment, with now there being some near-term events, both vaccine advisory committee (VRBPAC) and lawsuit-related.\"** Other vaccine makers like Pfizer PFE.N and Novavax NVAX.O up 1.6% and 6.7%, respectively** Mamtani cites recent late-stage study data for COVID-influenza combination and standalone flu vaccines as an additional driver for NVAX stock** Including sessions' moves, MRNA has lost 20.2% YTD, while NVAX is down 11.4%  (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}